VVD-159642

· Vividion Therapeutics, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for VVD-159642, covering 2026-03-18 to 2026-03-18. Get the full timeline:

Most recent: Clinical Trial Update: A First-in-Human (FIH) Study to Evaluate the Safety and Tolerability of VVD-159642 in Participants With Advanced Solid Tumors [Phase 1]

See pricing